Aryastha Life Sciences, a leading Contract Research and Development Organization in healthcare, has achieved a major milestone by successfully concluding its Series A funding with significant backing from Vessella Group, a prominent investor in India. A strategic funding boost from Vessella positions Aryastha to reshape drug discovery and development in the pharmaceutical and biotech sectors. With…